# Microvision, Inc.: overview MVIS · Nasdaq · CIK 65770 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/mvis.md) · [Financials](/companies/mvis/financials.md) · [Filings](/companies/mvis/filings.md) · [Insiders](/companies/mvis/insiders.md) Latest reported revenue: [$1.5m](/filings/0001493152-26-036371.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-036371). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.2](/filings/0001493152-25-021931.md) | [1.7 d](/filings/0001493152-26-008898.md) | [0.6](/filings/0001493152-26-023667.md) | [0.2](/filings/0001493152-26-036371.md) | [0.2](/filings/0001493152-25-021931.md) | [0.2 d](/filings/0001493152-26-008898.md) | [0.9](/filings/0001493152-26-023667.md) | [1.5](/filings/0001493152-26-036371.md) | | Gross margin | % | [(206.8%)](/filings/0001493152-25-021931.md) | [(149.5%) d](/filings/0001493152-26-008898.md) | [6.6%](/filings/0001493152-26-023667.md) | [(361.9%)](/filings/0001493152-26-036371.md) | [(297.1%)](/filings/0001493152-25-021931.md) | [(7220.6%) d](/filings/0001493152-26-008898.md) | [38.8%](/filings/0001493152-26-023667.md) | [43.6%](/filings/0001493152-26-036371.md) | | Operating margin | % | [(8266.3%)](/filings/0001493152-25-021931.md) | [(1119.5%) d](/filings/0001493152-26-008898.md) | [(2383.7%)](/filings/0001493152-26-023667.md) | [(9455.5%)](/filings/0001493152-26-036371.md) | [(5278.4%)](/filings/0001493152-25-021931.md) | [(18570.0%) d](/filings/0001493152-26-008898.md) | [(2512.7%)](/filings/0001493152-26-023667.md) | [(1643.7%)](/filings/0001493152-26-036371.md) | | Net margin | % | [(8166.8%)](/filings/0001493152-25-021931.md) | [(1888.2%) d](/filings/0001493152-26-008898.md) | [(4886.1%)](/filings/0001493152-26-023667.md) | [(9180.0%)](/filings/0001493152-26-036371.md) | [(5899.2%)](/filings/0001493152-25-021931.md) | [(16930.9%) d](/filings/0001493152-26-008898.md) | [(2705.2%)](/filings/0001493152-26-023667.md) | [(2508.0%)](/filings/0001493152-26-036371.md) | | Diluted EPS | $ per share | [(0.07)](/filings/0001493152-25-021931.md) | not reported | [(0.12)](/filings/0001493152-26-023667.md) | [(0.84)](/filings/0001493152-26-036371.md) | [(0.05)](/filings/0001493152-25-021931.md) | not reported | [(0.08)](/filings/0001493152-26-023667.md) | [(1.66)](/filings/0001493152-26-036371.md) | | Free cash flow | $m | [(14.1) d](/filings/0001493152-25-021931.md) | [(15.2) d](/filings/0001493152-26-008898.md) | [(14.2)](/filings/0001493152-26-023667.md) | [(12.9) d](/filings/0001493152-26-036371.md) | [(16.6) d](/filings/0001493152-25-021931.md) | [(15.6) d](/filings/0001493152-26-008898.md) | [(16.6)](/filings/0001493152-26-023667.md) | [(19.5) d](/filings/0001493152-26-036371.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [2.5](/filings/0001493152-24-008335.md) | [0.7](/filings/0001641172-25-000783.md) | [7.3](/filings/0001493152-26-008898.md) | [4.7](/filings/0001493152-26-008898.md) | [1.2](/filings/0001493152-26-008898.md) | | Gross margin | % | [99.9%](/filings/0001493152-24-008335.md) | [84.9%](/filings/0001641172-25-000783.md) | [61.8%](/filings/0001493152-26-008898.md) | [(60.3%)](/filings/0001493152-26-008898.md) | [(1435.4%)](/filings/0001493152-26-008898.md) | | Operating margin | % | [(1754.8%)](/filings/0001493152-24-008335.md) | [(8116.0%)](/filings/0001641172-25-000783.md) | [(1224.3%)](/filings/0001493152-26-008898.md) | [(1821.1%)](/filings/0001493152-26-008898.md) | [(6856.6%)](/filings/0001493152-26-008898.md) | | Net margin | % | [(1728.0%)](/filings/0001493152-24-008335.md) | [(7995.6%)](/filings/0001641172-25-000783.md) | [(1141.2%)](/filings/0001493152-26-008898.md) | [(2063.8%)](/filings/0001493152-26-008898.md) | [(7862.7%)](/filings/0001493152-26-008898.md) | | Diluted EPS | $ per share | [(0.27)](/filings/0001493152-24-008335.md) | [(0.32)](/filings/0001641172-25-000783.md) | [(0.45)](/filings/0001493152-26-008898.md) | [(0.46)](/filings/0001493152-26-008898.md) | [(0.35)](/filings/0001493152-26-008898.md) | | Free cash flow | $m | [(31.9)](/filings/0001493152-24-008335.md) | [(42.4)](/filings/0001641172-25-000783.md) | [(69.0)](/filings/0001493152-26-008898.md) | [(68.9)](/filings/0001493152-26-008898.md) | [(59.4)](/filings/0001493152-26-008898.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mvis/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [O'ROURKE & COMPANY, Inc](/funds/1911468.md) | 2026-06-30 | $29.5k | 90,219 | | New +90,219 | | [Quinn Opportunity Partners LLC](/funds/1633275.md) | 2026-06-30 | $6.5k | 20,000 | | New +20,000 | | [Strategic Wealth Partners, Ltd.](/funds/1720777.md) | 2026-06-30 | $286 | 875 | | New +875 | | [HOLLENCREST CAPITAL MANAGEMENT](/funds/1161722.md) | 2026-06-30 | $33 | 100 | | New +100 | ## Recent filings [All 1,025 filings](/companies/mvis/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-28 | 16:11 ET | [8-K](/filings/0001493152-26-048989.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-048989 | | 2026-10-07 | 16:05 ET | [8-K](/filings/0001493152-26-046140.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-046140 | | 2026-08-31 | 09:26 ET | [8-K](/filings/0001493152-26-040752.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-040752 | | 2026-08-17 | 16:08 ET | [8-K](/filings/0001493152-26-038743.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-038743 | | 2026-08-10 | 09:26 ET | [8-K](/filings/0001493152-26-036772.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-036772 | | 2026-08-06 | 16:43 ET | [10-Q](/filings/0001493152-26-036371.md) | Quarterly report, period 2026-06-30 | 0001493152-26-036371 | | 2026-08-06 | 16:17 ET | [8-K](/filings/0001493152-26-036350.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-036350 | | 2026-07-22 | 09:17 ET | [8-K](/filings/0001493152-26-034194.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-034194 | | 2026-07-13 | 16:01 ET | [8-K](/filings/0001493152-26-033018.md) | 5.07 Shareholder vote results | 0001493152-26-033018 | | 2026-07-07 | 09:15 ET | [8-K](/filings/0001493152-26-032266.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-032266 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-008898.md), filed Mar 4, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/02ce1a96-16f5-4d8b-8693-fbe6359b2843) ## About the filer - CIK: 65770 - Tickers: MVIS - Exchange: Nasdaq - SIC code: 3679 Electronic Components, NEC - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 06:10 ET. No prices; not investment advice.